youtube_live
Q3 2026 earnings • in 4 days
See detailschevron_right
INSM:NASDAQ
Insmed Inc
$93.39
arrow_downward
-1.76%(-1.67) 1D
$93.39
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:00:01 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INSM...
Open
$94.12
High
$94.64
Low
$92.62
Mkt. cap
20.39B
Avg. vol.
2.70M
Volume
3.41M
52-wk high
$212.75
52-wk low
$90.39
EPS
-$4.10
Beta
0.83
Shares outstanding
218.38M
No. of employees
2K
Open
$94.12
High
$94.64
Low
$92.62
Mkt. cap
20.39B
Avg. vol.
2.70M
Volume
3.41M
52-wk high
$212.75
52-wk low
$90.39
EPS
-$4.10
Beta
0.83
Shares outstanding
218.38M
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
3 days ago
Insmed (INSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
About Insmed Inc
CEOWilliam H. Lewis
Employees1.66K
Founded1988
HeadquartersBridgewater, New Jersey, United States
SectorBiotechnology
Websiteinsmed.com
Analyst ratings
Based on 21 analysts giving stock ratings to INSM in the past 3 months
Strong buy
Buy
20
Hold
1
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for INSM in the last 3 months.
Highest
Current $93.39
$243.00 (+160.20%)
Average
$196.16 (+110.04%)
Lowest
$169.00 (+80.96%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Maxwell Skor Morgan Stanley | Buy | Reiterated | $213.00 | +128.1% | 10/21/2026 |
Adam Walsh Roth MKM | Buy | Reiterated | $198.00 | +112% | 10/20/2026 |
Tiago Fauth Raymond James | Buy | Maintained | $173.00 | +85.2% | 10/20/2026 |
Benjamin Burnett Wells Fargo | Buy | Reiterated | $169.00 | +81% | 10/13/2026 |
Conor MacKay BMO Capital | Buy | Maintained | $192.00 | +105.6% | 10/12/2026 |
Andrew Fein H.C. Wainwright | Buy | Maintained | $220.00 | +135.6% | 10/12/2026 |
Jason Zemansky Bank of America Securities | Buy | Reiterated | $207.00 | +121.7% | 10/12/2026 |
Andy Chen Wolfe Research | Hold | Downgraded | - | - | 10/12/2026 |
Leonid Timashev RBC Capital | Buy | Maintained | $195.00 | +108.8% | 10/08/2026 |
Ashwani Verma UBS | Buy | Maintained | $172.00 | +84.2% | 10/07/2026 |
Graig Suvannavejh Mizuho Securities | Buy | Maintained | $195.00 | +108.8% | 10/05/2026 |
Eliana Merle Barclays | Buy | Maintained | $207.00 | +121.7% | 09/30/2026 |
Jessica Fye J.P. Morgan | Buy | Reiterated | $175.00 | +87.4% | 09/28/2026 |
Andrea Newkirk Goldman Sachs | Buy | Initiated | $188.00 | +101.3% | 09/24/2026 |
Danielle Brill Truist Financial | Buy | Reiterated | $195.00 | +108.8% | 08/10/2026 |
Olivia Brayer Cantor Fitzgerald | Buy | Maintained | $235.00 | +151.6% | 08/06/2026 |
Gavin Clark-Gartner Evercore ISI | Buy | Maintained | $170.00 | +82% | 08/07/2026 |
Vamil Divan Guggenheim | Buy | Reiterated | $205.00 | +119.5% | 08/06/2026 |
Ritu Baral TD Cowen | Buy | Maintained | $243.00 | +160.2% | 08/06/2026 |
Faisal Khurshid Jefferies | Buy | Maintained | $175.00 | +87.4% | 08/06/2026 |
Matt Phipps William Blair | Buy | Maintained | - | - | 08/06/2026 |
Evan Seigerman BMO Capital | Buy | Initiated | $192.00 | +105.6% | 07/21/2026 |
Unknown Analyst BMO Capital | Buy | Initiated | $192.00 | +105.6% | 07/20/2026 |
Stephen Willey Stifel Nicolaus | Buy | Maintained | $200.00 | +114.2% | 07/17/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $175.00 | +87.4% | 06/23/2026 |
Tyler Van Buren TD Cowen | Buy | Maintained | $243.00 | +160.2% | 05/20/2026 |
Unknown Analyst J.P. Morgan | Buy | Maintained | $180.00 | +92.7% | 05/20/2026 |
Unknown Analyst Evercore ISI | Buy | Maintained | $162.00 | +73.5% | 05/15/2026 |
Unknown Analyst Raymond James | Buy | Initiated | $200.00 | +114.2% | 04/09/2026 |
Next call in 4 days
Thu, Oct 29, 8:00 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / -$0.38
Revenue / Est. (USD)
- / 499.48M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 142.34M | 263.84M | 305.96M | 425.49M |
Cost of goods sold | 29.36M | 44.22M | 47.42M | 67.21M |
Cost of revenue | 29.36M | 44.22M | 47.42M | 67.21M |
Research and development expenses | 186.42M | 254.91M | 209.48M | 210.03M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 186.38M | 212.48M | 247.26M | 247.47M |
Operating expense | 374.33M | 469.33M | 458.82M | 459.58M |
Total operating expenses | 403.69M | 513.55M | 506.24M | 526.79M |
Operating income | -261.35M | -249.71M | -200.28M | -101.31M |
Other non operating income | -603.00K | -1.82M | -736.00K | -531.00K |
EBT including unusual items | -368.70M | -326.93M | -162.10M | -11.37M |
EBT excluding unusual items | -264.05M | -256.89M | -209.06M | -111.13M |
Income tax expense | 1.32M | 1.55M | 1.46M | 1.87M |
Effective tax rate | -0.36% | -0.47% | -0.90% | -16.43% |
Other operating expenses | - | - | - | - |
Net income | -370.02M | -328.48M | -163.56M | -13.24M |
Net profit margin | -259.95% | -124.50% | -53.46% | -3.11% |
Earnings per share | -1.75 | -1.54 | -0.76 | -0.06 |
Interest and investment income | 18.29M | 15.24M | 12.04M | 10.98M |
Interest expense | -20.38M | -20.60M | -20.08M | -20.27M |
Net interest expenses | -2.09M | -5.36M | -8.04M | -9.29M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -257.89M | -244.68M | -195.80M | -96.58M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1